Does RISANKIZUMAB Cause Covid-19? 35 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Covid-19 have been filed in association with RISANKIZUMAB (Skyrizi). This represents 1.3% of all adverse event reports for RISANKIZUMAB.
35
Reports of Covid-19 with RISANKIZUMAB
1.3%
of all RISANKIZUMAB reports
2
Deaths
8
Hospitalizations
How Dangerous Is Covid-19 From RISANKIZUMAB?
Of the 35 reports, 2 (5.7%) resulted in death, 8 (22.9%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for RISANKIZUMAB.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which RISANKIZUMAB Alternatives Have Lower Covid-19 Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL